Skip to Main content Skip to Navigation
Journal articles

DCC constrains tumour progression via its dependence receptor activity.

Abstract : The role of deleted in colorectal carcinoma (DCC) as a tumour suppressor has been a matter of debate for the past 15 years. DCC gene expression is lost or markedly reduced in the majority of advanced colorectal cancers and, by functioning as a dependence receptor, DCC has been shown to induce apoptosis unless engaged by its ligand, netrin-1 (ref. 2). However, so far no animal model has supported the view that the DCC loss-of-function is causally implicated as predisposing to aggressive cancer development. To investigate the role of DCC-induced apoptosis in the control of tumour progression, here we created a mouse model in which the pro-apoptotic activity of DCC is genetically silenced. Although the loss of DCC-induced apoptosis in this mouse model is not associated with a major disorganization of the intestines, it leads to spontaneous intestinal neoplasia at a relatively low frequency. Loss of DCC-induced apoptosis is also associated with an increase in the number and aggressiveness of intestinal tumours in a predisposing APC mutant context, resulting in the development of highly invasive adenocarcinomas. These results demonstrate that DCC functions as a tumour suppressor via its ability to trigger tumour cell apoptosis.
Keywords : Cancer Genetics Genomics
Document type :
Journal articles
Complete list of metadatas

https://www.hal.inserm.fr/inserm-00721045
Contributor : Alain Puisieux <>
Submitted on : Thursday, July 26, 2012 - 2:32:55 PM
Last modification on : Wednesday, June 10, 2020 - 6:42:05 PM

Links full text

Identifiers

Collections

Citation

Marie Castets, Laura Broutier, Yann Molin, Marie Brevet, Guillaume Chazot, et al.. DCC constrains tumour progression via its dependence receptor activity.. Nature, Nature Publishing Group, 2012, 482 (7386), pp.534-7. ⟨10.1038/nature10708⟩. ⟨inserm-00721045⟩

Share

Metrics

Record views

409